These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2790146)

  • 1. Antitumor activity of steroid-containing platinum (II) complexes of 1R,2R-cyclohexanediamine and 2-(aminomethyl)-cyclohexylamine isomers against leukemia L1210.
    Kidani Y; Suzuki K; Noji M; Tashiro T
    Biomed Pharmacother; 1989; 43(4):261-4. PubMed ID: 2790146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
    Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
    Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An orally active antitumor cyclohexanediamine-Pt(IV) complex: trans,cis,cis-bis(n-valerato)(oxalato)(1R,2R-cyclohexane diamine)Pt(IV).
    Kizu R; Nakanishi T; Miyazaki M; Tashiro T; Noji M; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Kidani Y
    Anticancer Drugs; 1996 May; 7(3):248-56. PubMed ID: 8791997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of conformation to antitumor activity of platinum(II) complexes of 1,2-cyclohexanediamine and 2-(aminomethyl)cyclohexylamine isomers against leukemia P388.
    Noji M; Okamoto K; Kidani Y; Tashiro T
    J Med Chem; 1981 May; 24(5):508-15. PubMed ID: 7241508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
    Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
    J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
    Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH
    J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure and antitumor activity of a water-soluble platinum complex, (1R,3R,4R,5R)-(-)-quinato(1R,2R-cyclohexanediamine)platinum (II).
    Hata G; Kitano Y; Kaneko T; Kawai H; Mutoh M
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1604-5. PubMed ID: 1394681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
    Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
    Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV).
    Kizu R; Nakanishi T; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Tashiro T; Kidani Y
    Cancer Chemother Pharmacol; 1999; 43(2):97-105. PubMed ID: 9923814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and antitumor activities of 1R,2R-cyclohexanediamine Pt(II) complexes containing dicarboxylates.
    Noji M; Suzuki K; Tashiro T; Suzuki M; Harada K; Masuda K; Kidani Y
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):221-8. PubMed ID: 3594651
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.
    Pendyala L; Kidani Y; Perez R; Wilkes J; Bernacki RJ; Creaven PJ
    Cancer Lett; 1995 Nov; 97(2):177-84. PubMed ID: 7497460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure and antitumor activity of a new water-soluble platinum complex, (1R,2R-cyclohexanediamine-N,N')[2-hydroxy-4-oxo-2-pentenoato(2-)-O2] platinum(II).
    Kawai H; Kitano Y; Mutoh M; Hata G
    Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):357-61. PubMed ID: 8500201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antitumor studies on platinum(II) and platinum(IV) complexes containing 1,2-diaminocyclohexane.
    Vollano JF; Al-Baker S; Dabrowiak JC; Schurig JE
    J Med Chem; 1987 Apr; 30(4):716-9. PubMed ID: 3560163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against (1R,2R)-cyclohexanediamineplatinum(II)-DNA adduct recognize the conformational differences of isomeric analogues of cyclohexanediamine.
    Yamada H; Kato T; Hirose J; Inagaki K; Noji M; Kidani Y
    Biochim Biophys Acta; 1990 Jul; 1049(3):298-302. PubMed ID: 2383586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    J Cancer Res Clin Oncol; 1994; 120(7):409-14. PubMed ID: 8188734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes.
    Siddik ZH; al-Baker S; Burditt TL; Khokhar AR
    J Cancer Res Clin Oncol; 1993; 120(1-2):12-6. PubMed ID: 8270602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effectivity of two diaminocyclohexane Pt-complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1985; 32(5):537-42. PubMed ID: 4069288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
    Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.